Alliance Global is excited to participate at the Seminar on Next Generation Sequencing – Clinical Applications in Oncology, to be held in King Faisal Specialist Hospital & Research Centre, Riyadh Saudi Arabia on the 21st of September 2017.
Dr. Yusuf Murgha, Application Scientist, will be representing AGBL at this event by giving a talk on “Routine genetic testing for cancer predisposition, diagnostics & monitoring therapeutics”
Speaker: Dr. Yusuf Murgha
Dr. Yusuf Murgha had done his PhD in Biomedical Engineering at the University of Michigan, USA. He specialized in developing methods to add value to microarray oligonucleotides pools. He later went on to join companies such as MYcroarray where he lead the development of oligonucleotide pools for cytogenetic assays and DNA oligonucleotide synthesis. In 2015, he joined Genotypic, India as
the NGS wet lab manager where he gained extensive experience in all aspect of lab management. Dr. Murgha has experience running an NGS core service lab offering multiple DNA and RNA applications on Illumina and Ion Torrent platforms. He has 4 methods publications for the development of NGS reagent kits.
The AGBL Group of companies is the largest biomedical gateway to the emerging markets of the Middle East, Africa and Asia. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the emerging healthcare markets within the MENA region. The group employs dedicated teams of product and applications specialists, and has many offices across the region offering distribution, consulting and product development services to world-renowned manufacturers of biomedical technologies. The group’s stated mission is to improve the lives of the region’s inhabitants through novel biomedical technologies and products.